Jinani Jayasekera

1.3k total citations · 1 hit paper
58 papers, 642 citations indexed

About

Jinani Jayasekera is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinani Jayasekera has authored 58 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 19 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinani Jayasekera's work include Global Cancer Incidence and Screening (27 papers), Breast Cancer Treatment Studies (13 papers) and BRCA gene mutations in cancer (10 papers). Jinani Jayasekera is often cited by papers focused on Global Cancer Incidence and Screening (27 papers), Breast Cancer Treatment Studies (13 papers) and BRCA gene mutations in cancer (10 papers). Jinani Jayasekera collaborates with scholars based in United States, Netherlands and Germany. Jinani Jayasekera's co-authors include Jeanne S. Mandelblatt, Clyde B. Schechter, Christopher J. Cadham, Kathryn L. Taylor, Rafael Meza, Pianpian Cao, Young Chandler, Jihyoun Jeon, Suzanne C. O’Neill and Claudine Isaacs and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jinani Jayasekera

54 papers receiving 628 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of Breast Cancer Mortality in the US—1975 to 2019

2024 89 citations John M. Hampton, Jinani Jayasekera et al. profile →

Peers

Countries citing papers authored by Jinani Jayasekera

Since Specialization

Citations

This map shows the geographic impact of Jinani Jayasekera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinani Jayasekera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinani Jayasekera more than expected).

Fields of papers citing papers by Jinani Jayasekera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinani Jayasekera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinani Jayasekera. The network helps show where Jinani Jayasekera may publish in the future.

Co-authorship network of co-authors of Jinani Jayasekera

This figure shows the co-authorship network connecting the top 25 collaborators of Jinani Jayasekera. A scholar is included among the top collaborators of Jinani Jayasekera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinani Jayasekera. Jinani Jayasekera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neighborhood walkability and sedentary behaviors among US adults 2026 ·Environmental Epidemiology ·(unknown), (unknown), (unknown), Jinani Jayasekera, (unknown), Tomoki Nakaya, (unknown), (unknown), (unknown), Kosuke Tamura	0
2	The Effects of Post-diagnosis Recreational Aerobic Exercise among Breast Cancer Survivors: A Systematic Review/Meta-Analysis 2025 ·Cancer Epidemiology Biomarkers & Prevention ·Oliver W.A. Wilson, Charles E. Matthews, (unknown), Yelena N. Tarasenko, Gisela Butera, Jessica Gorzelitz, Clyde B. Schechter, (unknown), Jinani Jayasekera	1
3	A systematic review of the relationship between neighborhood stressors, discrimination, and cardiometabolic outcomes during pregnancy 2025 ·PubMed ·(unknown), Kosuke Tamura, Jinani Jayasekera, Amina P. Alio, Allana T. Forde	0
4	Creating a Mammography Conversation Aid for Shared Decision‐Making Between Clinicians and Women Aged 75 and Older 2025 ·Journal of the American Geriatrics Society ·Mara A. Schonberg, Natasha K. Stout, Sarah Stein, (unknown), (unknown), (unknown), (unknown), Jeanne S. Mandelblatt, Víctor M. Montori, Ilana B. Richman, Daniel D. Matlock, (unknown), (unknown), (unknown), Jinani Jayasekera, Nancy L. Schoenborn	0
5	Recreational physical activity and health-related quality of life among breast cancer survivors: a systematic review 2025 ·Quality of Life Research ·(unknown), Oliver W.A. Wilson, (unknown), Gisela Butera, Jacob Schneider, Laura Q. Rogers, Wendy Demark‐Wahnefried, Jinani Jayasekera	1
6	The associations of muscle-strengthening exercise with recurrence and mortality among breast cancer survivors: a systematic review 2024 ·International Journal of Behavioral Nutrition and Physical Activity ·Oliver W.A. Wilson, (unknown), (unknown), Jessica Gorzelitz, Gisela Butera, Charles E. Matthews, Jinani Jayasekera	5
7	Clinical and sociodemographic determinants of older breast cancer survivors’ reports of receiving advice about exercise 2024 ·Breast Cancer Research and Treatment ·(unknown), Oliver W.A. Wilson, (unknown), Padma Sheila Rajagopal, Mara A. Schonberg, Jinani Jayasekera	1
8	Population simulation modeling of disparities in US breast cancer mortality 2023 ·JNCI Monographs ·Jeanne S. Mandelblatt, Clyde B. Schechter, Natasha K. Stout, Hui Huang, Sarah Stein, Christina Chapman, Amy Trentham‐Dietz, Jinani Jayasekera, Ronald E. Gangnon, John M. Hampton, Linn Abraham, Ellen S. O’Meara, Vanessa B. Sheppard, Sandra J. Lee	4
9	A health equity framework to support the next generation of cancer population simulation models 2023 ·JNCI Monographs ·Christina Chapman, Jinani Jayasekera, Chiranjeev Dash, Vanessa B. Sheppard, Jeanne S. Mandelblatt	9
10	Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting 2022 ·JNCI Cancer Spectrum ·Pianpian Cao, (unknown), Jeanne S. Mandelblatt, Jihyoun Jeon, Kathryn L. Taylor, Amy Zhao, David T. Levy, Randi M. Williams, Rafael Meza, Jinani Jayasekera	9
11	Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer 2022 ·Journal of Clinical Oncology ·Jinani Jayasekera, Amy Zhao, Clyde B. Schechter, Kathryn P. Lowry, Jennifer M. Yeh, Marc D. Schwartz, Suzanne C. O’Neill, Karen J. Wernli, Natasha K. Stout, Jeanne S. Mandelblatt, Allison W. Kurian, Claudine Isaacs	11
12	Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts 2021 ·PLoS Computational Biology ·Amy Trentham‐Dietz, Oğuzhan Alagöz, Christina Chapman, Xuelin Huang, Jinani Jayasekera, Nicolien T. van Ravesteyn, Sandra J. Lee, Clyde B. Schechter, Jennifer M. Yeh, Sylvia K. Plevritis, Jeanne S. Mandelblatt, (unknown)	10
13	Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study 2021 ·JNCI Journal of the National Cancer Institute ·Christopher J. Cadham, Pianpian Cao, Jinani Jayasekera, Kathryn L. Taylor, David T. Levy, Jihyoun Jeon, Elena B. Elkin, Kristie L. Foley, Anne M. Joseph, Chung Yin Kong, Jennifer A. Minnix, Nancy A. Rigotti, Benjamin A. Toll, Steven B. Zeliadt, Rafael Meza, Jeanne S. Mandelblatt	37
14	Development and Validation of a Simulation Model–Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions 2021 ·Journal of Clinical Oncology ·Jinani Jayasekera, Joseph A. Sparano, Suzanne C. O’Neill, Young Chandler, Claudine Isaacs, Allison W. Kurian, Lawrence H. Kushi, Clyde B. Schechter, Jeanne S. Mandelblatt	12
15	Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics 2021 ·Cancer Medicine ·Young Chandler, Clyde B. Schechter, Jinani Jayasekera, Claudine Isaacs, Allison W. Kurian, Christopher J. Cadham, Jeanne S. Mandelblatt	2
16	Effect of a Randomized Trial of a Web-Based Intervention on Patient–Provider Communication About Breast Density 2021 ·Journal of Women s Health ·Erin J. Aiello Bowles, Suzanne C. O’Neill, Tengfei Li, Sarah Knerr, Jeanne S. Mandelblatt, Marc D. Schwartz, Jinani Jayasekera, Kathleen A. Leppig, Kelly Ehrlich, David Farrell, Hongyuan Gao, Amanda L. Graham, George Luta, Karen J. Wernli	2
17	Question Prompt List to Support Patient-Provider Communication in the Use of the 21-Gene Recurrence Test: Feasibility, Acceptability, and Outcomes 2020 ·JCO Oncology Practice ·Jinani Jayasekera, Susan T. Vadaparampil, Susan Eggly, Richard L. Street, (unknown), Claudine Isaacs, Hyo S. Han, (unknown), Jennifer García, (unknown), Suzanne C. O’Neill	11
18	Simulation of Chemotherapy Effects in Older Breast Cancer Patients With High Recurrence Scores 2019 ·JNCI Journal of the National Cancer Institute ·Young Chandler, Jinani Jayasekera, Clyde B. Schechter, Claudine Isaacs, Christopher J. Cadham, Jeanne S. Mandelblatt	13
19	Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer 2019 ·JNCI Cancer Spectrum ·Jinani Jayasekera, Joseph A. Sparano, Robert J. Gray, Claudine Isaacs, Allison W. Kurian, Suzanne C. O’Neill, Clyde B. Schechter, Jeanne S. Mandelblatt	5
20	Prevalence of fixed dose drug combinations in nepal:A preliminary study 2010 ·JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH ·Arjun Poudel, Subish Palaian, (unknown), (unknown), Jinani Jayasekera	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact